GB Sciences Licenses Patent To Develop New Cannabis-Based Therapies For The Treatment Of Heart Disease
pharmaceutical investing Big Pharma Pushes Forward with Alzheimer's R&D but Medicinal Plants May be the Answer
Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock
UPDATE - Critical Metals Corp (NASDAQ: CRML) Secures Another Significant Tanbreez Offtake Agreement for 15% of its Production with Leading U.S. Vertically Integrated Rare Earth Company, REalloys Inc.
